BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21516988)

  • 1. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
    Tripathi A; Jerrell JM; Stallworth JR
    Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.
    Lê PQ; Gulbis B; Dedeken L; Dupont S; Vanderfaeillie A; Heijmans C; Huybrechts S; Devalck C; Efira A; Dresse MF; Rozen L; Benghiat FS; Ferster A
    Pediatr Blood Cancer; 2015 Nov; 62(11):1956-61. PubMed ID: 26173735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of hemoglobinopathies found in Belgium].
    Fondu P
    Bull Mem Acad R Med Belg; 1995; 150(10-11):367-75; discussion 376-8. PubMed ID: 8845787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?].
    De Montalembert M; Tshilolo L
    Med Trop (Mars); 2007 Dec; 67(6):612-6. PubMed ID: 18300525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
    Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
    Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
    PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of sickle cell disease].
    de Montalembert M
    Rev Prat; 2004 Sep; 54(14):1557-64. PubMed ID: 15558966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children.
    de Montalembert M; Ferster A; Colombatti R; Rees DC; Gulbis B;
    Am J Hematol; 2011 Jan; 86(1):72-5. PubMed ID: 20981677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
    Ware R
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding admission for afebrile pediatric sickle cell pain: pain management methods.
    Dumaplin CA
    J Pediatr Health Care; 2006; 20(2):115-22; quiz 123-5. PubMed ID: 16522488
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 17. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
    Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
    Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in sickle cell disease: the Belgian experience.
    Vermylen C; Cornu G; Ferster A; Ninane J; Sariban E
    Bone Marrow Transplant; 1993; 12 Suppl 1():116-7. PubMed ID: 8374550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.